FDA Inspection 1194208 — Innovative Blood Resources

Innovative Blood Resources — FEI 3003294594

The FDA completed an inspection of Innovative Blood Resources on December 14, 2022 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 14, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Lincoln, NE (United States)